NCT02335580View on ClinicalTrials.gov

Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis

CompletedOBSERVATIONAL
Enrollment

475

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Liver CirrhosisPortal VeinVenous ThrombosisVaricose VeinsHemorrhage
Interventions
DRUG

Somatostatin and its analogs

Somatostatin and/or octreotide will be intravenously infused.

PROCEDURE

Endoscopic sclerotherapy, endoscopic variceal ligation, endoscopic tissue glue injection

Endoscopic sclerotherapy, endoscopic variceal ligation, and/or endoscopic tissue glue injection will be performed based on the endoscopists' choice.

Trial Locations (1)

110840

Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER

NCT02335580 - Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis | Biotech Hunter | Biotech Hunter